Vogt-Koyanagi-Harada disease. Characteristics of a series of andalusian patients;Enfermedad de Vogt-Koyanagi-Harada. Características de un grupo de pacientes andaluces

Revista Clinica Espanola

Volumn 206, Issue 8, 2006, Pages 388-391

  Garcia Hernandez F J ^a   Ocana Medina C ^a   Castillo Palma, M J ^a   Sanchez Roman J ^a   Rueda Rueda, T ^a   Pulido Aguilera, M C ^a   Lopez Checa F ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Uveitis; Vogt Koyanagi Harada disease

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; GLUCOCORTICOID;

ADULT; ALOPECIA; ARTICLE; ASEPTIC MENINGITIS; AUDIOMETRY; CATARACT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; EYE SYNECHIA; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; HYPOACUSIS; INTRAOCULAR HYPOTENSION; IRIDOCYCLITIS; KERATOPATHY; MALE; RETINA DETACHMENT; RETROSPECTIVE STUDY; SYMPTOM; UVEITIS; VISUAL ACUITY; VISUAL DISORDER; VITILIGO; VITRECTOMY; VOGT KOYANAGI SYNDROME;

EID: 33749612161     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13090507     Document Type: Article

References (16)

1. Murakami S, Inaba Y, Mochizuki M, Nakajima A, Urayama A. A nationwide survey on the occurrence of Vogt-Koyanagi-Harada disease in Japan. Nippon Ganka Gakkai Zasshi. 1994;98:389-92.
2. Pivetti Pezzi P, Accorinti M, Colabelli Gisoldi RA, Pirraglia MP. Vogt-Koyanagi-Harada disease and HLA type in Italian patients. Am J Ophthalmol. 1996;122:889-91.
3. Bañares A, Jover JA, Fernández Gutiérrez B, Benítez del Castillo JM, García J, Vargas E, et al. Patterns of uveitis as a guide in making rheumatologic and immunologic diagnoses. Arthritis Rheum. 1997;40:358-70.
4. García O, Arcediano MA. Síndrome de Vogt-Koyanagi-Harada: revisión en el área de influencia de la CSUB. Annals d'Oftalmologia. 2001;9:24-8.
5. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39:265-92.
6. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes García L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international comittee on nomenclature. Am J Ophthalmol. 2001;131:647-52.
7. Minnakawa R, Ohno S, Hirose S, Kotake S, Miyajima T, Tagawa Y, et al. Clinical manifestations of Vogt Koyanagi Harada disease. Jpn J Clin Opohthalmol. 1985;39:1249-53.
8. Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001;131:599-606.
9. Mondkar SV, Biswas J, Ganesh SK. Analysis of 87 cases with Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 2000;44(3):296-301.
10. Ohno S, Char DH, Kimura SJ, O'Connor GR. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1977;83:735-40.
11. Sasamoto Y, Ohno S, Matsuda H. Studies on corticostertoid therapy in Vogt-Koyanagi-Harada disease. Ophthalmologica. 1990;201:162-7.
12. Nussenblatt RB. Clinical studies of Vogt-Koyanagi-Harada disease at the National Eye Institute, NIH, USA. Jpn J Ophthalmol. 1988;32:330-3.
13. Rubsamen PE, Gass JDM. Vogt-Koyanagi-Harada syndrome: clinical course, therapy, and long-terrn visual outcome. Arch Ophthalmol. 1991; 109:682-7.
14. Ikeda M, Tsukagoshi H. Vogt-Koyanagi-Harada disease presenting meningoencephalitis: report of a case with magnetic resonance imaging. Eur Neurol. 1992;32:83-5.
15. Nitta E, Takamori M. Wallenberg's syndrome in a case of Vogt-Koyanagi-Harada disease. Rinsho Shinkeigaku. 1989;29:505-8.
16. Helveston WR, Gilmore R. Treatment of Vogt-Koyanagi-Harada syndrome with intravenous immunoglobulin. Neurology. 1996;46:584-5.